Third-Line Treatment Options for Metastatic Colorectal Cancer - Episode 2
Nuances With Defining “Refractory” mCRC in the Third-Line Setting
Panelists discuss how “refractory” metastatic colorectal cancer (mCRC) is defined in the third- vs fourth-line setting, and the treatment goals in the third-line setting, focusing on optimizing patient outcomes and managing progression after prior therapies.
Video Player is loading.
How do you define “refractory” mCRC in the third- vs fourth-line setting, and what are your treatment goals in the third-line setting?
Related Content:
